| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |